Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2025-12-25 @ 7:15 PM
Study NCT ID:
NCT05488132
Status:
UNKNOWN
Last Update Posted:
2022-08-04
First Post:
2022-08-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)
Sponsor:
Xuzhou Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-02
First Submit QC Date:
None
Study First Post Date:
2022-08-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-02
Last Update Post Date:
2022-08-04
Last Update Post Date Type:
ACTUAL